author-photo

Maria Grazia Prisco

Catholic University of the Sacred Heart

18

Papers

634

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Estrogen receptor beta in cancer: an attractive target for therapy.

2012 Current Pharmaceutical Design
Show All
- Source
- Cite
- Save
Citations (42)
The estrogen receptor beta agonist diarylpropionitrile (DPN) inhibits medulloblastoma development via anti-proliferative and pro-apototic pathways.

2011 Cancer Letters
Show All
- Source
- Cite
- Save
Citations (24)
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer.

2011 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (58)
Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical–pathological and immunohistochemical study

2010 Virchows Archiv
Show All
- Source
- Cite
- Save
Citations (43)
Protective role of 17β‐estradiol on medulloblastoma development in Patched1 heterozygous mice

2010 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (10)
CD133 antigen expression in ovarian cancer

2009 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (79)
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients

2008 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (7)
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients

2008 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (14)